Twist Bioscience
TWST
93 hedge funds and large institutions have $415M invested in Twist Bioscience in 2019 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 33 increasing their positions, 19 reducing their positions, and 7 closing their positions.
214% more first-time investments, than exits
New positions opened: 22 | Existing positions closed: 7
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
74% more repeat investments, than reductions
Existing positions increased: 33 | Existing positions reduced: 19
11.46% more ownership
Funds ownership: 48.14% → 59.6% (+11%)
11% more capital invested
Capital invested by funds: $374M → $415M (+$40.2M)
11% more funds holding
Funds holding: 84 → 93 (+9)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital World Investors
Los Angeles,
California
|
+$16.5M |
| 2 |
Alyeska Investment Group
Chicago,
Illinois
|
+$11.4M |
| 3 |
BlackRock
New York
|
+$7.27M |
| 4 |
Millennium Management
New York
|
+$6.93M |
| 5 |
JP Morgan Chase
New York
|
+$4.42M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EA
Emerald Advisers
Leola,
Pennsylvania
|
-$5.33M |
| 2 |
EMFAT
Emerald Mutual Fund Advisers Trust
Leola,
Pennsylvania
|
-$4.9M |
| 3 |
IECM
Intrinsic Edge Capital Management
Chicago,
Illinois
|
-$4.22M |
| 4 |
CM
Castleark Management
Chicago,
Illinois
|
-$3.4M |
| 5 |
Barclays
London,
United Kingdom
|
-$1.52M |
TWST Hedge Fund Activity: Q4 2019 in Review
93 of the 5,092 institutional investors tracked by Wall St. Rank reported a position in Twist Bioscience (TWST) for Q4 2019, worth a combined $415M — up 11% from $374M a quarter earlier.
Buyers outnumbered sellers: 22 funds opened new TWST positions and 7 closed out — a net gain of 15 holders — while 33 added to existing stakes and 19 trimmed.
The largest buyer was Capital World Investors, opening a new position worth an estimated $16.5M. The largest seller was Emerald Advisers, cutting an estimated $5.33M.
- 93 institutional investors held Twist Bioscience (TWST) as of Q4 2019, up from 84 in Q3 2019.
- Funds reported $415M of Twist Bioscience stock for Q4 2019, up 11% quarter-over-quarter.
- 22 funds opened new Twist Bioscience positions in Q4 2019 and 7 closed out, a net change of +15 holders.
- The largest Twist Bioscience buyer in Q4 2019 was Capital World Investors, an estimated $16.5M added.
- The largest Twist Bioscience seller in Q4 2019 was Emerald Advisers, an estimated $5.33M sold.
Based on aggregated 13F filings for Q4 2019.